TSHA
Taysha Gene Therapies Inc
4.50$
+1.4%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -378.2% | -447.2% | -580.4% | -1,933.8% | -1,208.9% | -905.4% | -956.6% | -1,016.2% | – | -487.2% | – | – | -2,410.0% | |
| 7.0% | 10.2% | 9.5% | 29.0% | 16.4% | 15.0% | 12.3% | 13.9% | – | 5.5% | – | – | 21.3% | |
| 43.0% | 54.6% | 93.8% | 299.6% | 187.8% | 159.1% | 143.1% | 160.6% | – | 64.3% | – | – | 331.3% | |
| -155.3% | -134.5% | 8.7% | -385.1% | -329.0% | -128.6% | -197.9% | 112.1% | – | -128.9% | – | – | -53.3% | |
| 73.7% | 0.5% | 4.1% | 18.1% | 2.0% | 0.1% | 16.4% | 0.1% | – | 4.6% | – | – | 61.7% | |
| -73.5% | -0.3% | -4.1% | -18.1% | -2.0% | 0.6% | -16.1% | 3.1% | – | -4.5% | – | – | -60.5% | |
| – | -11.7% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | 0.0% | – | – | – | |
| 2,963.2% | -117.9% | -0.6% | 6,337.1% | 368.8% | -17.7% | -2.3% | 10,890.6% | – | 903.5% | – | – | 5,026.8% | |
| 2,511.5% | -565.3% | -585.2% | 4,385.2% | -842.0% | -922.5% | -974.9% | 9,877.5% | – | 411.8% | – | – | 2,556.2% | |
| -451.9% | -447.7% | -584.5% | -1,951.9% | -1,210.9% | -905.3% | -973.0% | -1,016.3% | – | -491.7% | – | – | -2,471.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.